Skip to content

riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU

Risk Factors for Neck Phlegmon After Percutaneous Tracheostomy in ICU

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06552676
Acronym
SORCERER
Enrollment
300
Registered
2024-08-14
Start date
2018-08-09
Completion date
2025-01-31
Last updated
2024-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Tracheostomy Complication

Brief summary

Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy. Participant Population/Primary Condition: Patients admitted to Intensive Care Main Questions Aims to Answer: 1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life? Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons. At the two-year follow-up, the health-related quality of life will be assessed

Interventions

Percutaneous tracheostomy is a widely used technique in intensive care. It involves creating a passage between the tracheal lumen and the outside, through which a cannula is placed.

Sponsors

Azienda Usl di Bologna
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age greater than 18 years * Presence of indication for tracheostomy

Exclusion criteria

* Failure of the percutaneous tracheostomy technique or recourse to surgical tracheostomy

Design outcomes

Primary

MeasureTime frameDescription
Neck phlegmon7 daysNeck phlegmon in the incisional site

Secondary

MeasureTime frameDescription
Intensive Care Stay1 yearDays of ICU stay
Hospital Stay1 yearDays of hospital stay
Mortality30 days30 days mortality
Dysphonia2 yearsVoice Handicap Index - VHI-10 questionnaire
Dysphagia2 yearsEating Attitude test - EAT-10 questionnaire
Dyspnoea2 yearsModified Medical Research Council Dyspnea Scale - mMRC-10
Cough2 yearsLeicester Cough Questionnaire - LCQ
Health related quality of life2 years15D instrument

Countries

Italy

Contacts

Primary ContactLorenzo Gamberini, MD
gamberini6@ausl.bologna.it+393403550540

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026